Several common medications lower PSA levels, sometimes significantly. The most powerful are drugs prescribed specifically for enlarged prostates, which cut PSA roughly in half. But cholesterol medications, blood pressure pills, aspirin, and even diabetes drugs can also push PSA down by smaller amounts. Understanding which drugs affect PSA matters because an artificially low reading can complicate prostate cancer screening.
5-Alpha Reductase Inhibitors Have the Largest Effect
Finasteride and dutasteride, prescribed for enlarged prostates and male pattern hair loss, are the drugs with the most dramatic impact on PSA. They work by blocking the enzyme that converts testosterone into a more potent form that drives prostate growth. As the prostate shrinks, it produces less PSA.
Most of the PSA decrease happens within the first three months of starting treatment. By six months, PSA typically drops by about 50% from its starting value. This reduction is so predictable that doctors use a simple rule: if your PSA doesn’t fall to half its original level after six months on finasteride or dutasteride, persistent elevation could signal an underlying problem like prostate cancer.
Because these drugs reliably halve PSA, the standard clinical practice is to double your measured PSA value to estimate what it would be without the medication. Most urologists use “doubled PSA greater than 4 ng/mL” as a trigger for considering a prostate biopsy. If you’re taking one of these drugs, your doctor should already be applying this correction factor when interpreting your screening results. If you’re not sure whether they are, it’s worth asking.
Statins Lower PSA by About 13%
Cholesterol-lowering statin drugs are associated with modestly lower PSA levels. An analysis of national health data found that five years of statin use was linked to PSA levels about 13% lower than in non-users. Not all statins appear to have the same effect. Atorvastatin (Lipitor) was associated with an 18.6% reduction in PSA among men without prostate cancer, while simvastatin showed no significant effect.
The mechanism isn’t fully understood. Statins may limit the raw materials cells need to produce hormones, reduce inflammation around the prostate, or physically prevent PSA from leaking into the bloodstream. Whatever the pathway, the reduction is real enough that researchers have flagged it as a potential source of screening interference. A 13% drop won’t usually change a borderline result dramatically, but it could nudge someone just below a biopsy threshold.
Aspirin Has a Surprisingly Large Association
Regular aspirin use is linked to meaningfully lower PSA. In one study, aspirin users had a baseline PSA of 5.17 ng/mL compared to 7.58 ng/mL in non-users, a difference of roughly 32%. The effect was especially pronounced in men who had never smoked, where aspirin users had PSA levels 49% lower than non-users.
Interestingly, other NSAIDs like ibuprofen and naproxen did not show the same pattern. Their association with PSA was tiny (under 5%) and not statistically significant. This suggests the effect isn’t simply about reducing inflammation. Aspirin has unique properties, including its ability to irreversibly block certain enzymes, that may explain why it stands apart from other pain relievers.
Thiazide Diuretics Reduce PSA by Up to 26%
Thiazide diuretics, a class of blood pressure medications, are associated with notably lower PSA. Five years of thiazide use was linked to PSA levels 26% lower than in non-users, making these among the most impactful non-prostate drugs on the list. Even after one year, PSA was about 6% lower.
Researchers believe thiazides may work through two routes. First, they alter vitamin D metabolism, and vitamin D is known to influence how much PSA prostate cells release. Second, thiazides may reduce the amount of biologically active testosterone in the body. One study found that bioavailable testosterone dropped by roughly 30% in older men taking thiazides compared to controls. Less testosterone stimulating the prostate means less PSA production. The effect held regardless of whether men were also taking other blood pressure medications like beta blockers or ACE inhibitors.
Metformin and Diabetes
Metformin, the most widely prescribed diabetes drug, has been linked to lower PSA levels in several studies. A Canadian study found a dose-response pattern: the more metformin patients with type 2 diabetes took, the lower their PSA tended to be. U.S. national health survey data similarly showed that metformin users with diabetes had lower PSA than diabetic patients not taking the drug.
There’s a complicating wrinkle here. Diabetes itself appears to lower PSA, possibly through hormonal changes associated with insulin resistance and obesity. So disentangling metformin’s independent effect from the effects of diabetes has been difficult. One small trial in non-diabetic men with advanced prostate cancer found that metformin at high doses reduced PSA and stabilized disease after 12 weeks, hinting at a direct effect. But the evidence is still too mixed to draw firm conclusions about how much metformin matters for PSA screening in the average patient.
Hormone Therapy for Prostate Cancer
Androgen deprivation therapy, used to treat prostate cancer rather than to affect screening, suppresses PSA far more aggressively than any of the drugs above. By cutting off the testosterone that fuels prostate cancer cells, these treatments drive PSA to near-undetectable levels. About 77% of high-risk prostate cancer patients treated with hormone therapy and radiation reached a PSA nadir below 0.06 ng/mL, essentially a trace amount.
For men on these treatments, PSA is used as a monitoring tool rather than a screening tool. Doctors track the lowest point PSA reaches (the nadir) and watch for any rise of 2 ng/mL or more above that floor, which signals possible recurrence. The timeline to reach the lowest PSA point varies, but reaching it within six months is considered a favorable sign.
Saw Palmetto Does Not Affect PSA
Despite its popularity as a prostate supplement, saw palmetto does not lower PSA levels. A clinical trial that tested increasing doses of saw palmetto extract found no significant effect on PSA readings, even at higher-than-usual amounts. This is actually useful information: if you’re taking saw palmetto for urinary symptoms, your PSA results remain reliable for screening purposes. The same cannot be said for most of the prescription medications listed above.
What This Means for Screening
If you’re taking any combination of statins, thiazides, aspirin, finasteride, or dutasteride, your PSA reading could be substantially lower than it would otherwise be. For 5-alpha reductase inhibitors, the correction is straightforward: double the measured value. For other medications, there’s no widely adopted correction formula, which means a low PSA could provide false reassurance.
The practical takeaway is to make sure whoever orders your PSA test knows every medication you’re taking, including over-the-counter aspirin. A PSA of 3.5 ng/mL looks reassuring on paper, but if you’re on finasteride and a thiazide, the corrected value could be well above the typical 4.0 ng/mL threshold that prompts further evaluation. The drugs themselves aren’t dangerous in this context. The risk is in misreading what your PSA number actually means.